TCP
ELV icon

Tourbillon Capital Partners’s Elevance Health ELV Stock Holding History

Tourbillon Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-111,106
Closed -$26.4M – 48
2018
Q2 		$26.4M Sell
111,106
-8,894
-7% -$2.06M 1.02% 33
2018
Q1 		$26.4M Buy
+120,000
New +$28.2M 1.05% 34

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tourbillon Capital Partners's ELV Position: Q3 2018 in Review

Tourbillon Capital Partners sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 111,106 shares — an estimated $26.4M sold.

Tourbillon Capital Partners first reported a position in ELV in Q1 2018 and held it in 2 quarters. The position peaked at $26.4M in Q2 2018. 946 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

  • Tourbillon Capital Partners reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
  • Tourbillon Capital Partners sold 111,106 Elevance Health shares in Q3 2018, an estimated $26.4M.
  • Tourbillon Capital Partners first reported a position in Elevance Health in Q1 2018 and held it in 2 quarters.
  • Tourbillon Capital Partners's Elevance Health position peaked at $26.4M in Q2 2018.
  • 946 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Tourbillon Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.